Approval · Notice of Compliance 17191 · 2015
ENGAIN 20: Notice of Compliance 17191
Issued August 13, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17191
- Date
- August 13, 2015
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Addition of drug product manufacturing sites
- Therapeutic class
- Beta-adrenergic agonist and growth promotant
- Canadian reference product
- PAYLEAN 20
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ENGAIN 20 | 02426447 | Cancelled Post Market |
Medicinal ingredients
- RACTOPAMINE HCL 20 G per KG